6 hours ago
1
Andrii Dodonov/iStock via Getty Images
- Dyne Therapeutics (NASDAQ:DYN) shares rose on Wednesday after the company's CEO, John Cox, bought 100,000 shares of the company.
- The stock is up 6%.
- The CEO bought 100,000 shares between a price range of $9.02 and $9.15 per share, totaling approximately $911,000.
More on Dyne Therapeutics
- Dyne Therapeutics: Emergence As A Superior DM1/DMD Player Warrants Rating Upgrade
- Dyne Therapeutics announces public offering of common stock
- Dyne falls amid delay in clinical program for muscle disorder therapy
- Seeking Alpha’s Quant Rating on Dyne Therapeutics
- Historical earnings data for Dyne Therapeutics
English (US) ·